As European markets face challenges from political instability and economic uncertainties, the pan-European STOXX Europe 600 Index has recently seen a decline. Despite these broader market concerns, penny stocks continue to capture investor interest due to their potential for growth at lower price points. Often representing smaller or newer companies, these stocks can offer significant opportunities when backed by strong financials and solid fundamentals.
Top 10 Penny Stocks In Europe
Name | Share Price | Market Cap | Rewards & Risks |
Ariston Holding (BIT:ARIS) | €4.172 | €1.44B | ✅ 5 ⚠️ 2 View Analysis > |
Maps (BIT:MAPS) | €3.34 | €44.36M | ✅ 4 ⚠️ 2 View Analysis > |
Angler Gaming (NGM:ANGL) | SEK3.60 | SEK269.95M | ✅ 4 ⚠️ 2 View Analysis > |
Angler Gaming (DB:0QM) | €0.37 | €259.45M | ✅ 2 ⚠️ 2 View Analysis > |
Cellularline (BIT:CELL) | €3.12 | €65.81M | ✅ 4 ⚠️ 2 View Analysis > |
Euroland Société anonyme (ENXTPA:ALERO) | €3.02 | €9.58M | ✅ 2 ⚠️ 5 View Analysis > |
ForFarmers (ENXTAM:FFARM) | €4.435 | €391.99M | ✅ 4 ⚠️ 1 View Analysis > |
High (ENXTPA:HCO) | €3.66 | €71.95M | ✅ 1 ⚠️ 4 View Analysis > |
Deceuninck (ENXTBR:DECB) | €2.075 | €286.81M | ✅ 4 ⚠️ 1 View Analysis > |
Netgem (ENXTPA:ALNTG) | €0.93 | €31.36M | ✅ 4 ⚠️ 2 View Analysis > |
Click here to see the full list of 327 stocks from our European Penny Stocks screener.
Underneath we present a selection of stocks filtered out by our screen.
ELES Semiconductor Equipment (BIT:ELES)
Simply Wall St Financial Health Rating: ★★★★★★
Overview: ELES Semiconductor Equipment S.p.A. designs, manufactures, and sells test equipment and solutions for the semiconductor industry both in Italy and internationally, with a market cap of €40.89 million.
Operations: The company's revenue is primarily derived from its Semiconductor Equipment and Services segment, which generated €35.73 million.
Market Cap: €40.89M
ELES Semiconductor Equipment S.p.A. is experiencing significant developments, with Mare Engineering Group S.p.A.'s unsolicited bid to acquire a substantial stake in the company, currently holding over 17% of its share capital. The offer's cash consideration of €2.25 per share reflects market interest despite ELES's high volatility and relatively low return on equity at 4.5%. Financially, the company has improved its debt position and achieved a notable earnings growth of 55.6% over the past year, although this was partly influenced by large one-off items impacting results. Its short-term assets comfortably cover both short- and long-term liabilities.
- Dive into the specifics of ELES Semiconductor Equipment here with our thorough balance sheet health report.
- Assess ELES Semiconductor Equipment's future earnings estimates with our detailed growth reports.
Turbon (DB:TUR)
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: Turbon AG develops, produces, and sells typeface printing accessories across Europe, the United States, and Asia with a market cap of €6.28 million.
Operations: No specific revenue segments are reported for Turbon AG.
Market Cap: €6.28M
Turbon AG, with a market cap of €6.28 million, has faced challenges as it reported a net loss of €0.49 million for the first half of 2025 compared to a net income the previous year. Despite being unprofitable, Turbon has reduced its losses over the past five years and maintains more cash than debt, indicating financial prudence. The company's short-term assets significantly exceed both its short- and long-term liabilities, providing some stability amid volatility in share price and earnings performance. Its board is seasoned with an average tenure of 12.3 years, suggesting experienced governance during this turbulent period.
- Navigate through the intricacies of Turbon with our comprehensive balance sheet health report here.
- Explore historical data to track Turbon's performance over time in our past results report.
Nexam Chemical Holding (OM:NEXAM)
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: Nexam Chemical Holding AB (publ) develops solutions to enhance the properties and performance of plastics across Sweden, Europe, and internationally with a market cap of SEK327.71 million.
Operations: The company's revenue is divided into two segments: Performance Chemicals, generating SEK85.10 million, and Performance Masterbatch, contributing SEK111.21 million.
Market Cap: SEK327.71M
Nexam Chemical Holding AB, with a market cap of SEK327.71 million, remains unprofitable despite generating SEK196.31 million in revenue from its Performance Chemicals and Masterbatch segments. The company reported increased losses in the first half of 2025, with a net loss of SEK7.39 million compared to SEK3.22 million the previous year. While trading significantly below estimated fair value, Nexam has seen its debt-to-equity ratio improve over five years to 17.1%. Short-term assets exceed liabilities, providing some financial stability despite less than a year's cash runway and negative return on equity at -7.45%.
- Click here to discover the nuances of Nexam Chemical Holding with our detailed analytical financial health report.
- Understand Nexam Chemical Holding's earnings outlook by examining our growth report.
Next Steps
- Explore the 327 names from our European Penny Stocks screener here.
- Want To Explore Some Alternatives? Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if Nexam Chemical Holding might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com